Catalyst Crew Technologies CEO to Attend HLTH Europe 2026, Seeking Strategic Growth in Digital Health
Catalyst Crew Technologies Corp. announced its CEO will attend HLTH Europe 2026 to explore partnerships and market trends, supporting its expansion in AI-driven telehealth for emerging markets.
Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company focused on emerging markets, announced that Dr. Kevin Rodan Levy, its Chief Executive Officer, plans to attend HLTH Europe 2026. The conference, scheduled for June 15-18 in Amsterdam, convenes healthcare executives, innovators, investors, and technology leaders to discuss digital health transformation and emerging technologies.
The Company stated that Dr. Levy’s attendance is intended to support its broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of its evolving digital health ecosystem. According to the press release, the Company believes that attending major international healthcare conferences may provide valuable opportunities to observe industry developments, strengthen professional networks, and support its broader efforts to advance its telehealth and artificial intelligence healthcare platform strategy.
Dr. Levy said, “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”
The Company continues to advance the development of its telehealth platform infrastructure, AI healthcare modules, and broader digital health strategy across Latin America and emerging markets. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement is significant as it signals Catalyst Crew’s commitment to scaling its presence in the global digital health space. HLTH Europe is a premier event for healthcare innovation, and the Company’s participation could lead to partnerships, investments, or technology insights that accelerate its AI-enabled healthcare platform. For a development-stage company targeting underserved markets in Latin America, exposure to international trends and networks is crucial for building credibility and securing the resources needed to commercialize its solutions.
The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
However, the Company faces risks typical of early-stage ventures. It has not generated revenues from its newly announced business direction, and there is no assurance that it will successfully implement its business plan, secure financing, or obtain regulatory approvals. The press release includes forward-looking statements and cautions that actual results may differ materially from expectations.